Agreement of self-reported use of menopausal hormone replacement therapy with physician reports

Meera G. Jain, Thomas E. Rohan, Geoffrey R. Howe

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

There have been relatively few epidemiological studies to verify the information obtained from study participants on the use of menopausal hormone replacement therapy. We conducted this study as part of a case-control study of diet, hormone use, and endometrial cancer in Toronto, Ontario, Canada, 1994-1998. We compared records from 653 subjects, 30-79 years of age, with reports from their physicians on ever/never use of hormone replacement therapy and duration, type, and dose of hormone replacement therapy. A total of 88% of the interview records were in agreement with physician reports for ever/never use of hormone replacement therapy. The overall kappa value for ever/never use agreement was 0.76 (range = 0.71-0.81), and the intraclass correlation coefficient was 0.64 (range = 0.57-0.70) for duration of hormone replacement therapy use, indicating good agreement; similar correlations were seen among cases and controls for overall use, as well as estrogen- or progestogen-alone use. Concordance for brand codes was observed for about 43% of the subjects. This study suggests that information obtained by interview in case-control studies provides a reasonable measure of ever use of hormone replacement therapy and duration of use. Interviews, however, do not represent a reliable source of information on brands and dosage of hormone replacement therapy preparations.

Original languageEnglish (US)
Pages (from-to)260-263
Number of pages4
JournalEpidemiology
Volume10
Issue number3
StatePublished - May 1999
Externally publishedYes

Fingerprint

Hormone Replacement Therapy
Physicians
Interviews
Case-Control Studies
Ontario
Progestins
Endometrial Neoplasms
Canada
Epidemiologic Studies
Estrogens
Hormones
Diet

Keywords

  • Data collection
  • Epidemiologic methods
  • Estrogens
  • Hormone replacement therapy
  • Progestogens
  • Subject-physician agreement

ASJC Scopus subject areas

  • Epidemiology

Cite this

Agreement of self-reported use of menopausal hormone replacement therapy with physician reports. / Jain, Meera G.; Rohan, Thomas E.; Howe, Geoffrey R.

In: Epidemiology, Vol. 10, No. 3, 05.1999, p. 260-263.

Research output: Contribution to journalArticle

@article{5840f5bef58b4ea1b875ad046c06a0d4,
title = "Agreement of self-reported use of menopausal hormone replacement therapy with physician reports",
abstract = "There have been relatively few epidemiological studies to verify the information obtained from study participants on the use of menopausal hormone replacement therapy. We conducted this study as part of a case-control study of diet, hormone use, and endometrial cancer in Toronto, Ontario, Canada, 1994-1998. We compared records from 653 subjects, 30-79 years of age, with reports from their physicians on ever/never use of hormone replacement therapy and duration, type, and dose of hormone replacement therapy. A total of 88{\%} of the interview records were in agreement with physician reports for ever/never use of hormone replacement therapy. The overall kappa value for ever/never use agreement was 0.76 (range = 0.71-0.81), and the intraclass correlation coefficient was 0.64 (range = 0.57-0.70) for duration of hormone replacement therapy use, indicating good agreement; similar correlations were seen among cases and controls for overall use, as well as estrogen- or progestogen-alone use. Concordance for brand codes was observed for about 43{\%} of the subjects. This study suggests that information obtained by interview in case-control studies provides a reasonable measure of ever use of hormone replacement therapy and duration of use. Interviews, however, do not represent a reliable source of information on brands and dosage of hormone replacement therapy preparations.",
keywords = "Data collection, Epidemiologic methods, Estrogens, Hormone replacement therapy, Progestogens, Subject-physician agreement",
author = "Jain, {Meera G.} and Rohan, {Thomas E.} and Howe, {Geoffrey R.}",
year = "1999",
month = "5",
language = "English (US)",
volume = "10",
pages = "260--263",
journal = "Epidemiology",
issn = "1044-3983",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Agreement of self-reported use of menopausal hormone replacement therapy with physician reports

AU - Jain, Meera G.

AU - Rohan, Thomas E.

AU - Howe, Geoffrey R.

PY - 1999/5

Y1 - 1999/5

N2 - There have been relatively few epidemiological studies to verify the information obtained from study participants on the use of menopausal hormone replacement therapy. We conducted this study as part of a case-control study of diet, hormone use, and endometrial cancer in Toronto, Ontario, Canada, 1994-1998. We compared records from 653 subjects, 30-79 years of age, with reports from their physicians on ever/never use of hormone replacement therapy and duration, type, and dose of hormone replacement therapy. A total of 88% of the interview records were in agreement with physician reports for ever/never use of hormone replacement therapy. The overall kappa value for ever/never use agreement was 0.76 (range = 0.71-0.81), and the intraclass correlation coefficient was 0.64 (range = 0.57-0.70) for duration of hormone replacement therapy use, indicating good agreement; similar correlations were seen among cases and controls for overall use, as well as estrogen- or progestogen-alone use. Concordance for brand codes was observed for about 43% of the subjects. This study suggests that information obtained by interview in case-control studies provides a reasonable measure of ever use of hormone replacement therapy and duration of use. Interviews, however, do not represent a reliable source of information on brands and dosage of hormone replacement therapy preparations.

AB - There have been relatively few epidemiological studies to verify the information obtained from study participants on the use of menopausal hormone replacement therapy. We conducted this study as part of a case-control study of diet, hormone use, and endometrial cancer in Toronto, Ontario, Canada, 1994-1998. We compared records from 653 subjects, 30-79 years of age, with reports from their physicians on ever/never use of hormone replacement therapy and duration, type, and dose of hormone replacement therapy. A total of 88% of the interview records were in agreement with physician reports for ever/never use of hormone replacement therapy. The overall kappa value for ever/never use agreement was 0.76 (range = 0.71-0.81), and the intraclass correlation coefficient was 0.64 (range = 0.57-0.70) for duration of hormone replacement therapy use, indicating good agreement; similar correlations were seen among cases and controls for overall use, as well as estrogen- or progestogen-alone use. Concordance for brand codes was observed for about 43% of the subjects. This study suggests that information obtained by interview in case-control studies provides a reasonable measure of ever use of hormone replacement therapy and duration of use. Interviews, however, do not represent a reliable source of information on brands and dosage of hormone replacement therapy preparations.

KW - Data collection

KW - Epidemiologic methods

KW - Estrogens

KW - Hormone replacement therapy

KW - Progestogens

KW - Subject-physician agreement

UR - http://www.scopus.com/inward/record.url?scp=0032952916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032952916&partnerID=8YFLogxK

M3 - Article

C2 - 10230835

AN - SCOPUS:0032952916

VL - 10

SP - 260

EP - 263

JO - Epidemiology

JF - Epidemiology

SN - 1044-3983

IS - 3

ER -